About Codetta
Codetta is a Healthcare company based in Morrisville (United States) founded in 2021. Omics clinical data is analyzed through an online platform. Codetta has raised $27.28 million across 2 funding rounds from investors including Anzu Partners, Genoa Ventures and VC23. Codetta offers products and services including Concerto System and Sonata Services. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include Helix, Benchling and BioAge Labs; 3 of its 3 listed competitors have raised funding.
Company details
Codetta was founded in 2021 and is based in Morrisville, United States. An online platform is provided for the analysis of omics clinical data, including reagents, hardware, and software. Simultaneous, multiplexed, and multi-omic analyses are enabled for liquid biopsy samples as well as isolated DNA, RNA, and protein. Operations focus on the biotechnology sector, supporting clinical research and diagnostics.
- Headquarters Morrisville, United States
- SectorsHealthcare
- Website codettabio.com
- Total Equity Funding$27.28M (USD)
in 2 rounds
- Latest Funding Round$12.28M (USD), Series A
May 2024
- InvestorsAnzu Partners
& 2 more
Products & Services of Codetta
Codetta offers a comprehensive portfolio of products and services, including Concerto System and Sonata Services.
Platform for harmonized multi-omics biomarker detection and analysis.
Customized projects for multi-omics testing and proof-of-concept work.
Funding Insights of Codetta
Codetta has successfully raised a total of $27.28M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $12.28 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27.28M
- Total Rounds 2
- Last Round Series A — $12.28M
- First Round $15M
(Apr 2022)
- Investors Count 3
All 2 funding rounds of Codetta with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $12.28M | Series A | – | – | – |
| Apr 2022 | $15M | Series A | – | Anzu Partners |
3 investors in total: 3 institutional.
Investors in Codetta
Codetta has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Anzu Partners, Genoa Ventures and VC23.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in industrial and life sciences technology companies. | anzupartners.com | Washington, Dc, United States | ||
Early-stage VC firm focused on life science startups | genoavc.com | San Francisco, United States | ||
Venture capital firm investing in the life sciences sector | vc23investors.com | Avon, United States |
Investor details for Codetta
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Codetta
6 people are tracked at Codetta (4 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Tj Johnson | CEO | Leadership |
Jay Gerlach | Vice President, Marketing | Leadership |
William Henley | Scientific Co-founder And Vice President Of Research And Innovation | Leadership |
William H. | Scientific Co-founder And Vice President Of Research And Innovation | Leadership |
Rowena Moss | Assay Development Manager | Team |
Joe Gaiteri | Principal Assay Scientist | Team |
Complete people profiles for Codetta
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Codetta
3 dated milestones of Codetta across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Codetta is founded.
- Funding First funding round of $15.0M.
- Funding Latest funding round, Series A, of $12.3M.
Competitors of Codetta
Codetta has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and BioAge Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. |
Detailed competitors of Codetta
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Codetta
The website of Codetta (codettabio.com) receives about 3K visits a month.
- Monthly visits3K
▲ 15.2% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Codetta (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Codetta
Complete news archive for Codetta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Codetta
Codetta was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Codetta is headquartered in Morrisville, United States.
Codetta is a funded company, having raised a total of $27.28M across 2 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Apr 2022.
Codetta was founded in 2021 and is based in Morrisville, United States. An online platform is provided for the analysis of omics clinical data, including reagents, hardware, and software. Simultaneous, multiplexed, and multi-omic analyses are enabled for liquid biopsy samples as well as isolated DNA, RNA, and protein. Operations focus on the biotechnology sector, supporting clinical research and diagnostics.
Codetta's top competitors include Helix, Benchling and BioAge Labs.
Codetta offers Concerto System and Sonata Services.
Codetta has 3 investors. Key investors include Anzu Partners, Genoa Ventures, and VC23.